1Life Healthcare, Inc. (NASDAQ:ONEM) Director David P. Kennedy Sells 2,778 Shares

1Life Healthcare, Inc. (NASDAQ:ONEM) Director David P. Kennedy sold 2,778 shares of the business’s stock in a transaction dated Monday, July 19th. The shares were sold at an average price of $26.49, for a total value of $73,589.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

NASDAQ:ONEM opened at $28.11 on Thursday. The company has a quick ratio of 5.49, a current ratio of 5.53 and a debt-to-equity ratio of 0.64. The company has a 50 day simple moving average of $33.07. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of -39.04 and a beta of 1.30. 1Life Healthcare, Inc. has a 12-month low of $25.30 and a 12-month high of $59.82.

1Life Healthcare (NASDAQ:ONEM) last released its quarterly earnings data on Tuesday, May 11th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.15). The business had revenue of $121.40 million during the quarter, compared to the consensus estimate of $116.15 million. 1Life Healthcare had a negative net margin of 22.27% and a negative return on equity of 18.06%. 1Life Healthcare’s quarterly revenue was up 54.1% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.40) EPS. On average, equities research analysts forecast that 1Life Healthcare, Inc. will post -0.84 earnings per share for the current fiscal year.

A number of research analysts have issued reports on ONEM shares. Canaccord Genuity decreased their target price on 1Life Healthcare from $56.00 to $48.00 and set a “buy” rating for the company in a research note on Tuesday, June 29th. Zacks Investment Research cut 1Life Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, June 11th. Citigroup reduced their price objective on 1Life Healthcare from $61.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, May 13th. Credit Suisse Group reduced their price objective on 1Life Healthcare from $56.00 to $50.00 and set an “outperform” rating for the company in a research report on Monday, May 17th. They noted that the move was a valuation call. Finally, reduced their price objective on 1Life Healthcare from $61.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, May 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and fourteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $47.31.

A number of large investors have recently added to or reduced their stakes in ONEM. Los Angeles Capital Management LLC raised its stake in 1Life Healthcare by 1.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 50,613 shares of the company’s stock valued at $2,209,000 after buying an additional 545 shares during the period. Wells Fargo & Company MN raised its stake in 1Life Healthcare by 25.7% in the fourth quarter. Wells Fargo & Company MN now owns 123,183 shares of the company’s stock valued at $5,377,000 after buying an additional 25,220 shares during the period. Rhumbline Advisers increased its stake in shares of 1Life Healthcare by 11.7% during the fourth quarter. Rhumbline Advisers now owns 96,940 shares of the company’s stock worth $4,231,000 after purchasing an additional 10,156 shares during the period. Citigroup Inc. increased its stake in shares of 1Life Healthcare by 325.8% during the fourth quarter. Citigroup Inc. now owns 17,442 shares of the company’s stock worth $761,000 after purchasing an additional 13,346 shares during the period. Finally, Berman Capital Advisors LLC bought a new position in shares of 1Life Healthcare during the fourth quarter worth approximately $237,000. Hedge funds and other institutional investors own 83.97% of the company’s stock.

About 1Life Healthcare

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.

Featured Story: What is the Difference Between Common Shares and Convertible Shares?

Insider Buying and Selling by Quarter for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.